COL7A1 and recessive dystrophic epidermolysis bullosa: Additionally, we report the successful application of gentamicin read-through therapy in an adult RDEB patient harboring a nonsense COL7A1 mutation (p.Gln1886Ter), supporting its therapeutic promise.